Juliana Draibe Selected Research

(Z)- 2- amino- 5- chlorobenzophenonamidinohydrazone acetate (G 256)

5/2022

Kidney Biopsy in Patients with Cancer along the Last Decade: A Multicenter Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Juliana Draibe Research Topics

Disease

7	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2022 - 09/2014
4	Inflammation (Inflammations) 04/2022 - 01/2018
3	IGA Glomerulonephritis (IGA Nephropathy) 04/2022 - 07/2015
3	Proteinuria 01/2022 - 06/2017
2	Neoplasms (Cancer) 06/2022 - 02/2021
2	Hematuria 05/2022 - 01/2018
2	Autoimmune Diseases (Autoimmune Disease) 04/2022 - 11/2016
2	Glomerulonephritis 04/2022 - 11/2016
2	Acute Tubulointerstitial Nephritis 07/2021 - 06/2020
2	Membranous Glomerulonephritis (Membranous Nephropathy) 10/2020 - 07/2015
2	Renal Insufficiency (Renal Failure) 01/2020 - 07/2015
2	Vasculitis (Vasculitides) 01/2018 - 01/2015
2	Nephrotic Syndrome (Syndrome, Nephrotic) 10/2017 - 06/2017
1	Paraproteinemias (Monoclonal Gammopathy) 10/2022
1	Lupus Nephritis 04/2022
1	Albuminuria 01/2022
1	Nephritis 01/2022
1	Necrosis 07/2021
1	Hypersensitivity (Allergy) 06/2020
1	Hypertension (High Blood Pressure) 10/2019
1	Thrombotic Microangiopathies 10/2019
1	Malignant Hypertension 10/2019
1	Thrombosis (Thrombus) 11/2016
1	Hereditary Nephritis (Alport Syndrome) 07/2015
1	Polycystic Kidney Diseases (Polycystic Kidney Disease) 07/2015
1	Hemolytic-Uremic Syndrome 07/2015
1	Acute Disease 09/2014

Drug/Important Bio-Agent (IBA)

6	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 04/2022 - 09/2014
4	CytokinesIBA 04/2022 - 06/2020
3	CreatinineIBA 05/2022 - 11/2016
3	Myeloblastin (Proteinase 3)IBA 01/2022 - 09/2014
3	AntibodiesIBA 01/2022 - 11/2019
3	Biomarkers (Surrogate Marker)IBA 07/2021 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 05/2022 - 11/2016
2	Peroxidase (Myeloperoxidase)IBA 01/2022 - 11/2019
2	eculizumab FDA Link 10/2019 - 07/2015
2	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2018 - 11/2016
2	SteroidsIBA 10/2017 - 06/2017
2	Rituximab (Mabthera)FDA Link 06/2017 - 09/2014
1	(Z)- 2- amino- 5- chlorobenzophenonamidinohydrazone acetate (G 256)IBA 05/2022
1	InflammasomesIBA 04/2022
1	Caspase 1 (ICE Protease)IBA 04/2022
1	Interleukin-18 (Interleukin 18)IBA 04/2022
1	antiglomerular basement membrane antibodyIBA 04/2022
1	COVID-19 VaccinesIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Complement C3 (C3 Complement)IBA 01/2022
1	VaccinesIBA 01/2022
1	Phospholipase A2 ReceptorsIBA 10/2020
1	ChemokinesIBA 06/2020
1	Pharmaceutical PreparationsIBA 06/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020
1	Complement System Proteins (Complement)IBA 10/2019
1	C-Reactive ProteinIBA 01/2018
1	Tacrolimus (Prograf)FDA LinkGeneric 06/2017
1	Urea (Carbamide)FDA LinkGeneric 11/2016
1	paquinimodIBA 11/2016
1	quinoline-3-carboxamideIBA 11/2016
1	Tolvaptan FDA Link 07/2015
1	Rheumatoid FactorIBA 01/2015
1	AutoantibodiesIBA 09/2014

Therapy/Procedure

4	Therapeutics 10/2022 - 10/2017
2	Immunotherapy 06/2022 - 02/2021
1	Drug Therapy (Chemotherapy) 06/2022
1	Conservative Treatment 01/2020
1	Plasmapheresis 10/2019